Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126003131 | 12600313 | 1 | I | 20160720 | 20160727 | 20160727 | EXP | PHHY2016US100119 | SANDOZ | HAN Z, KANE BM, PETTY LA, JOSEPHSON MA, SUTOR J, PURSELL KJ. COBICISTAT SIGNIFICANTLY INCREASES TACROLIMUS SERUM CONCENTRATIONS IN A RENAL TRANSPLANT RECIPIENT WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION.. PHARMACOTHERAPY. 2016;36(6):E50-E53 | 50.00 | YR | M | Y | 0.00000 | 20160727 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126003131 | 12600313 | 1 | PS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 2 MG, Q12H | U | 65461 | 2 | MG | Q12H | ||||||
| 126003131 | 12600313 | 2 | I | STRIBILD | COBICISTATELVITEGRAVIREMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 1 DF, QD | Y | 0 | 1 | DF | QD | ||||||
| 126003131 | 12600313 | 3 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126003131 | 12600313 | 1 | HIV infection |
| 126003131 | 12600313 | 2 | HIV infection |
| 126003131 | 12600313 | 3 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126003131 | 12600313 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126003131 | 12600313 | Acute kidney injury | |
| 126003131 | 12600313 | Drug interaction | |
| 126003131 | 12600313 | Drug level above therapeutic | |
| 126003131 | 12600313 | Hyperkalaemia | |
| 126003131 | 12600313 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |